The number of Zofran lawsuits continue to rise as women continue to give birth to children with birth defects after taking Zofran during pregnancy. Birth defects that have been linked with Zofran include cleft palate, congenital heart defect, and kidney defects. Zofran is prescribed to pregnant woman to help reduce morning sickness; however, it was never approved for that use.
On January 22, 2016, United States District Judge F. Dennis Saylor IV denied pharmaceutical giant GlaxoSmithKline’s motion to dismiss lawsuits filed against the company regarding its anti-nausea medication Zofran. Many women who took Zofran for morning sickness during pregnancy gave birth to babies born with severe abnormalities, including cleft palates, congenital heart defects, club feet, vision and hearing issues, and
There are few circumstances more tragic than a child born with severe birth defects. Many women who took GlaxoSmithKline’s drug Zofran for morning sickness during their pregnancies gave birth to babies born with congenital heart defects, cleft palates and other abnormalities. Zofran was approved by the FDA to prevent nausea and vomiting in cancer patients undergoing chemotherapy. Soon after, it